One of the works that illustrated this decision showed a SMA patient with four copies of SMN2 who developed SMA type 2 symptoms at the age of 8 months [41], a SMA type that may evolve into severe symptoms such as respiratory insufficiency and dysphagia [44]. This evidence concerns the gene SMN2 and spinal muscular atrophy, type II.